Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 20 Apr 2026 for Ultragenyx Pharmaceutical Inc..
Filing timeline
BuySaleJohn Richard Pinion
Insider track record
Disclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John Richard Pinion: trading record in brief
John Richard Pinion, listed as chief executive, appears in our data through filings on Ultragenyx Pharmaceutical Inc. shares, published by SEC (Form 4). Between 16 July 2015 and 16 April 2026, the trades on record add up to 51 filings.
On the market, this insider has only sold: 12 sales, €2.6M in total. Outside the open market, there are 38 share grants. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 20 April 2026, the filings show a share grant in Ultragenyx Pharmaceutical Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Richard Pinion
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
23,116 shares0Common StockSEC:0001193125-26-164289:0
11,137 shares0Common StockSEC:0001193125-26-089287:0
14,494 shares0Common StockSEC:0000950170-25-032785:0
17,800 shares0Common StockSEC:0000950170-24-026648:0
2,012 shares@ US$50.0019.5% of flowCommon StockSEC:0001209191-23-030931:0
2,663 shares0Common StockSEC:0001209191-23-016042:0
4,498 shares@ US$66.620.011% mcap69.3% of flowCommon StockSEC:0001209191-22-015823:0
358 shares@ US$81.146.0% of flowCommon StockSEC:0001209191-21-060748:0
363 shares@ US$113.698.1% of flowCommon StockSEC:0001209191-21-031387:0
9 of 9 declarations
